(Q36081997)

12 August 2017

1 reference

title

Toxicity of the topoisomerase II inhibitors (English)

1 reference

12 August 2017

Karen Seiter

1

1 reference

12 August 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Expert Opinion on Drug Safety

12 August 2017

published in

1 reference

12 August 2017

volume

4

1 reference

12 August 2017

issue

2

1 reference

12 August 2017

page(s)

219-234

1 reference

Intensive single-agent mitoxantrone for metastatic breast cancer

12 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Mitoxantrone in progressive multiple sclerosis: a placebo-controlled, double-blind, randomised, multicentre trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Idarubicin cardiotoxicity: a retrospective study in acute myeloid leukemia and myelodysplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Liposomal encapsulation diminishes daunorubicin-induced generation of reactive oxygen species, depletion of ATP and necrotic cell death in human leukaemic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

A phase I dose-escalating study of DaunoXome, liposomal daunorubicin, in metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Reduced cardiotoxicity and preserved antitumor efficacy of liposome-encapsulated doxorubicin and cyclophosphamide compared with conventional doxorubicin and cyclophosphamide in a randomized, multicenter trial of metastatic breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Genetic pathways in therapy-related myelodysplasia and acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Balanced chromosome abnormalities inv(16) and t(15;17) in therapy-related myelodysplastic syndromes and acute leukemia: report from an international workshop.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Secondary acute myelogenous leukemia and myelodysplasia without abnormalities of chromosome 11q23 following treatment of acute leukemia with topoisomerase II-based chemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

Secondary leukemias in refractory germ cell tumor patients undergoing autologous stem-cell transplantation using high-dose etoposide

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740338.4.2.219

21 January 2018

Identifiers

DOI

10.1517/14740338.4.2.219

1 reference

12 August 2017

1 reference